BCR-ABL1 (p210) Monitoring Assay
Chronic Myeloid Leukemia (CML)
CommercialNMPA Approved
Key Facts
Indication
Chronic Myeloid Leukemia (CML)
Phase
Commercial
Status
NMPA Approved
Company
About Sniper Medical Technologies
Developer of FDA, CE, and NMPA-approved fully automated digital PCR systems for precision molecular diagnostics.
View full company profileTherapeutic Areas
Other Chronic Myeloid Leukemia (CML) Drugs
| Drug | Company | Phase |
|---|---|---|
| XS003 (nilotinib) | Xspray Pharma | NDA Submitted |
| Scemblix® (asciminib) | Novartis | Approved / Lifecycle |
| TERN-701 | Terns Pharmaceuticals | Phase 3 |
| ELVN-001 | Enliven Therapeutics | Phase 1b |